Choate represented Victress Capital in the transaction.Droplette, the consumer skincare technology originally developed as a medical device to treat rare and debilitating skin diseases, executed the $15.4…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
